论文部分内容阅读
本研究通过选取具有代表性的3个县，采用成本效果分析和成本效益分析的方法，尝试性地对四川省世界银行贷款中国结核病控制项目进行了经济评价。结果表明：项目的成本效果比为258元／治愈1例病，27．2元／挽救1生命年，项目对于项目前的增量成本效果比为495元／治愈1例病人，24．1元／挽救1生命年，项目的成本效益比为1／16．7，项目对于项目前的增量成本效益比为1／18．9。通过本研究可以了解到：四川省项目是个成本效果、成本效益好的卫生干预措施，其实施是经济合理的。
This study tries to economically evaluate the TB control project funded by World Bank Loan in Sichuan by selecting three representative counties and using cost-effectiveness analysis and cost-benefit analysis. The results showed that the cost-effectiveness ratio of the project was 258 yuan / cure 1 case disease, 27.2 yuan / saving one life year, and the project cost-effectiveness ratio was 495 yuan / cure 1 case before the project, 24.1 yuan / Saving 1 life year, the cost-effectiveness ratio of the project is 1 / 16.7, and the project’s pre-project incremental cost-benefit ratio is 1 / 18.9. Through this study, we can see that the Sichuan Provincial Project is a cost-effective and cost-effective health intervention that is economically and reasonably implemented.